ArticleBritish journal of cancer2006

Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma.

R Maruyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.